This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Ferring B.v.. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: **Wolfgang Oliver Wachs: Innovator in Peptide Manufacturing**
Introduction
Wolfgang Oliver Wachs is a distinguished inventor based in Nykoebing Sjaelland, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the manufacture of peptide compounds. With a total of two patents to his name, Wachs continues to push the boundaries of innovation in peptide synthesis.
Latest Patents
Wachs' latest patents focus on the "Process for the manufacture of degarelix and its intermediates." This invention outlines a liquid-phase manufacturing process for preparing the decapeptide Degarelix, alongside its protected precursors and other valuable intermediates. The inventive process also emphasizes the purification of Degarelix itself. According to the patent, Degarelix can be synthesized by treating a precursor compound with a cleaving agent in an organic solvent, utilizing various amino protecting groups to facilitate the process.
Career Highlights
Currently, Wolfgang Wachs is associated with Ferring B.V., a global biotechnology company dedicated to the development of innovative medicines. His work in peptide synthesis has not only advanced scientific understanding but also has practical applications in therapeutic settings. Wachs' contributions have gained recognition within the industry, showcasing his commitment to innovation.
Collaborations
Wachs has collaborated with notable colleagues, including Stefan Hansen and Palle Hedengran Rasmussen. Together, they have worked on various projects aimed at enhancing peptide manufacturing processes, demonstrating the collaborative spirit that fosters innovation in the pharmaceutical field.
Conclusion
Wolfgang Oliver Wachs stands out as a key inventor in peptide manufacturing, particularly with his groundbreaking work on Degarelix. Through his patents and collaborations, he exemplifies how innovation can lead to significant advancements in healthcare. His contributions will undoubtedly leave a lasting impact on the pharmaceutical industry for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile